开盘$90.09
昨收$91.14
当日区间$88.42 – $91.51
成交量444.0K
市值$4.96B
市盈率（TTM）25.8
股息率–
LIVN 相关新闻
匹配 LivaNova 或代码 LIVN 的头条新闻，按最新排序。
- Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $90 正面
- Needham Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $93 正面
- Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating
- Analysts' Opinions Are Mixed on These Healthcare Stocks: LivaNova (LIVN), Gain Therapeutics (GANX) and Tempus AI, Inc. Class A (TEM) 正面
- Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $95 正面
- Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $87 正面
- KeyBanc Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $92 正面
- Baird Maintains LivaNova(LIVN.US) With Buy Rating, Cuts Target Price to $76 负面
- Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $90 正面
- A Quick Look at Today's Ratings for LivaNova(LIVN.US), With a Forecast Between $72 to $90
- Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $85
- Needham Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $81
- Goldman Sachs Maintains LivaNova(LIVN.US) With Hold Rating, Maintains Target Price $73
- A Quick Look at Today's Ratings for LivaNova(LIVN.US), With a Forecast Between $73 to $85
- Needham Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $81 正面
暂无评论——快来第一个聊聊 LIVN。
登录后参与讨论。